Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,603 | -2,810 | -2,538 | -1,362 | -2,210 |
| Depreciation Amortization | 754 | 583 | 413 | 241 | 960 |
| Accounts receivable | -1,626 | -949 | -492 | -604 | -398 |
| Accounts payable and accrued liabilities | -1,294 | -753 | -270 | -596 | -1,942 |
| Other Working Capital | -2,139 | -1,184 | 125 | -880 | -2,940 |
| Other Operating Activity | 3,320 | 1,706 | 685 | 1,206 | 2,390 |
| Operating Cash Flow | $-3,588 | $-3,408 | $-2,078 | $-1,994 | $-4,140 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 4,104 | 4,104 | 4,115 | -5 | -100 |
| Purchase Sale Intangibles | -525 | -525 | -525 | -200 | -100 |
| Other Investing Activity | -525 | -525 | -525 | -200 | -100 |
| Investing Cash Flow | $3,579 | $3,579 | $3,590 | $-205 | $-200 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,892 | 5,892 | 5,892 | 5,833 | 149 |
| Dividend Paid | -218 | -167 | -115 | -62 | -400 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 6,361 |
| Financing Cash Flow | $5,674 | $5,725 | $5,776 | $5,771 | $6,110 |
| Exchange Rate Effect | -52 | -54 | -49 | -52 | -90 |
| Beginning Cash Position | 1,982 | 1,982 | 1,982 | 1,982 | 310 |
| End Cash Position | 7,595 | 7,823 | 9,221 | 5,502 | 1,980 |
| Net Cash Flow | $5,613 | $5,841 | $7,239 | $3,520 | $1,660 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,588 | -3,408 | -2,078 | -1,994 | -4,140 |
| Capital Expenditure | -16 | -16 | -5 | -5 | -109 |
| Free Cash Flow | -3,604 | -3,424 | -2,083 | -2,000 | -4,249 |